Frequently Asked Questions (FAQ’s)
Many of these questions will be answered in the informed consent document associated with a specific clinical trial. This list of commonly asked questions is offered as a starting point for your discussions with our research team.
- Who is the primary physician overseeing my medical care while I am participating in the trial?
- Have my primary cardiologist and family doctor been consulted about this clinical trial?
- Why do the physician-researchers involved in this study believe this new investigated treatment might be helpful?
- Why was I selected to be a potential participant?
- What does the “phase number” of the clinical trial mean to my participation?
- Will I be hospitalized overnight as part of my participation?
- Has a variation of this treatment or technique been tested before?
- What are the possible risks, side effects and benefits of this therapy compared to my current treatment plan?
- What are my options if I am injured by the new treatment or procedure?
- What types of tests, appointments or procedures will be done at St. Vincent Heart Center?
- How long will the study last?
- Am I paid for my participation and/or reimbursed for expenses?
- What type of long-term follow-up is planned for this study?
- If I benefit from the new treatment, will I be allowed to continue receiving the drug medication after the trial ends?
- When will I know the results of the clinical trial?